Bone Graft Substitute Market Research Report: Information By Product Type (Allograft, {Machine allografts, Demineralized Bone Matrix (DBM)}, Bone Graft, Substitute {Synthetic Bone Grafts, Bone Morphogenic Proteins}, Cell-based Matrices), By Application (Spinal Fusion, Joint Reconstruction, Long Bone, Dental, Foot & Ankle), and Region (North America, Europe, Asia-Pacific, and Rest of the World)—Forecast till 2030
The Bone Graft Substitute Market is projected to reach USD 2,121.66 million by 2030 at 6.80% CAGR during the forecast period 2022-2030. Bone grafting is a medical procedure used to repair severe bone fractures. Bone grafts are implantable materials that are used in the surgical process to help with bone healing, bone formation, and osseous reconstruction. Implantable materials called bone grafts are utilized during surgery to promote bone development, bone healing, and osseous reconstruction. In place of autogenous or allogenous bone, a bone substitute is a synthetic, artificial, or biologically organic fusion that can be employed to cure a bone deficiency.
Some of the major drivers propelling market expansion include the rise in demand for dental bone graft procedures, the development of biocompatible synthetic bone grafts, and an increase in the frequency of joint disorders and road accidents. High surgical expenses, the dangers of bone graft procedures, and complications all limit the market expansion for bone transplant alternatives.
Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/1195
A novel line of calcium-phosphate and biological bone substitutes called BIOCERA-VET has been created by THERAVET. When a bone graft is necessary during bone surgeries, BIOCERA-VET® is a full line of innovative, simple-to-use, successful, and affordable bone substitutes that are also used as a palliative alternative in the treatment of canine osteosarcoma.
The number of accidents on the road is rising. For instance, the WHO estimates that 20 to 50 million people experience non-fatal injuries each year and 1.35 million people die in traffic accidents. The National Trauma Institute also calculates that the cost of trauma cases, including lost productivity and medical expenses, grew to USD 671 billion in 2014. Bone grafting can be used to treat a variety of ailments and wounds. It may be utilized if a fracture has numerous, complicated, or poor healing following initial therapy. It is also employed in sick joints for fusion, which promotes the repair of two bones. The spine is frequently the site of fusion.
Bone Graft Substitutes Market Segmentation
The market for synthetic bone grafts, bone morphogenic proteins, and cell-based matrices has been segmented based on the product type into allograft, machine allografts, and demineralized bone matrix (DBM). The market for bone graft substitutes is dominated by the spinal fusion segment. Allografts originate from someone other than the graft recipient. The majority of the time, it comes from cadavers who have donated their bone to a bone bank, where it can be utilised to help others who are still alive and in need.
The global market for bone graft substitutes is segmented based on application into spinal fusion, joint reconstruction, long bone, dental, foot, and ankle. The segment of the spinal fusion will expand the quickest. It’s important to understand that bone grafts cannot conduct spinal fusion or relieve spinal pain. A bone graft, however, creates an environment in which a solid bridge can form. A bone transplant that supports the spine also enables the body to rebuild the bone and fuse the injured area of the spine.
Bone Graft Substitutes Market Regional Analysis
The global market has been segmented into four regions based on geography: North America, Europe, Asia-Pacific, and the Rest of the World. The largest market share was in Europe. The region with the highest expected CAGR over the study period is Asia-Pacific.
The market for bone graft substitutes was dominated by Europe. Europe has become an important market due to rising healthcare expenditures and increased awareness of alternatives to bone grafts. The area has a sizable growth potential, which will contribute to the future growth of the global market. It is anticipated that nations like the UK and Germany would significantly contribute to the expansion of the regional market, which will be advantageous to the sector.
In Asia-Pacific, the bone graft substitute market is anticipated to expand at the fastest rate. The region has attractive opportunities for companies in the bone graft substitute market because of the presence of developing economies like India, China, and South Korea as well as the expanding prospective patient population. The market is also predicted to increase over the research period as a result of the expanding elderly population and rising healthcare costs. Due to research and development efforts, the Asia-Pacific region’s bone graft market is growing quickly
Browse In-depth Market Research Report (126 Pages) on Bone Graft Substitute: https://www.marketresearchfuture.com/reports/bone-graft-substitutes-market-1195
Bone Graft Substitutes Market Key players
Medtronic, AlloSource, Zimmer Biomet Holdings Inc, Stryker, Smith & Nephew, Johnson & Johnson Services Inc, Baxter International Inc, Integra Lifesciences Holdings Corporation, Orthofix Holdings Inc, Geistlich Pharma, and SeaSpine are well-known companies in the global bone graft substitute industry.
Browse Related Reports at:
Dental Bone Graft Substitutes Market Research Report: by Type (Allograft, Xenograft, Alloplast), by Application (Ridge Augmentation, Sinus Lift, Socket Preservation, Periodontal Defect), by End User (Dental Clinics and Hospitals) – Forecast Till 2030
Regenerative Medicine Market: Information by Type (Cell Therapy, Gene Therapy, Tissue Engineering, Small Molecule & Biologic), by Material (Synthetic, Genetically Engineered, Biologically Derived), by Application (Musculoskeletal Disorders, Wound Care, Oncology,Ocular Disorders,Diabetes), by End User (Hospitals, Specialty Centers, Academic & Research Institutes), and Region (Americas, Europe, Asia-Pacific, and Middle East & Africa)—Forecast till 2030
Musculoskeletal System Disorders Market Research Report: By Type (Rheumatoid Arthritis, Osteoarthritis, Osteoporosis, Psoriatic Arthritis, Ankylosing Spondylitis), Treatment (Biologics, Corticosteroids, Physical Therapy, Protein Therapy, Composite Grafts) and End User (Hospitals and Clinics, Ambulatory Surgical Centers) – Forecast to 2030
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com